Regenacy Completes Enrollment for PII Study in Diabetic Peripheral Neuropathy
24 Aug 2022 //
BUSINESSWIRE
Regenacy Announces the Formation of a Joint Venture with 3E Bioventures
21 Dec 2020 //
BUSINESSWIRE
Regenacy Announces the Formation of a Joint Venture with 3E Bioventures
21 Dec 2020 //
BUSINESSWIRE